Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Formation en compétences de communication empathique pour les fournisseurs de soins contre le cancer afin d'aider à mettre fin à la stigmatisation du cancer du poumon vécue par les patients

6 octobre 2026 mis à jour par: Memorial Sloan Kettering Cancer Center

Formation en compétences de communication empathique pour réduire la stigmatisation du cancer du poumon

Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.

Aperçu de l'étude

Description détaillée

The aims of this study are:

  1. to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out);

  2. to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction).

    Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and

  3. to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics).

Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.

Type d'étude

Interventionnel

Inscription (Estimé)

1232

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

  • Nom: Smita Banerjee, PhD
  • Numéro de téléphone: 646-888-0011
  • E-mail: banerjes@mskcc.org

Lieux d'étude

    • California
      • Irvine, California, États-Unis, 92612
        • Complété
        • Providence St. Joseph Health (Data Collection Only)
    • Florida
      • Miami, Florida, États-Unis, 33143
        • Recrutement
        • BAPTIST ALLIANCE - MCI (Data Collection Only)
        • Contact:
          • Ian Bostock, MD
          • Numéro de téléphone: 786-596-2000
    • Illinois
      • Libertyville, Illinois, États-Unis, 60048
        • Recrutement
        • Advocate Health Care Network
        • Contact:
          • Michael Breen, MD
          • Numéro de téléphone: 847-367-6781
    • Kentucky
      • Lexington, Kentucky, États-Unis, 40536-0093
        • Complété
        • University of Kentucky (Data Collection Only)
    • Michigan
      • Traverse City, Michigan, États-Unis, 49684
        • Complété
        • Munson Healthcare (Data Collection Only)
    • New Jersey
      • Hackensack, New Jersey, États-Unis, 07601
        • Recrutement
        • Hackensack Meridian Health (Data collection only)
        • Contact:
          • David Greenberg, MD
          • Numéro de téléphone: 551-996-8704
    • New York
      • Buffalo, New York, États-Unis, 14263-0001
        • Recrutement
        • Roswell Park Cancer Institute (Data Collection Only)
        • Contact:
          • Elisabeth Dexter, MD
          • Numéro de téléphone: 716-845-2300
      • New York, New York, États-Unis, 10065
        • Recrutement
        • Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        • Contact:
          • Smita Banerjee, PhD
          • Numéro de téléphone: 646-888-0011
    • Pennsylvania
      • Philadelphia, Pennsylvania, États-Unis, 19111
        • Recrutement
        • Fox Chase Cancer Center (Data Collection Only)
        • Contact:
          • Linda Fleisher, PhD, MPH
          • Numéro de téléphone: 215-728-4066
      • Philadelphia, Pennsylvania, États-Unis, 19104-4283
        • Recrutement
        • University of Pennsylvania (Data Collection Only)
        • Contact:
          • Victoria Sherry, DNP, CRNP, ANP-BC, AOCNP
          • Numéro de téléphone: (215) 615-5858
      • Philadelphia, Pennsylvania, États-Unis, 08060
        • Complété
        • Virtua Health (Data Collection Only)
    • Virginia
      • Chesapeake, Virginia, États-Unis, 23320
        • Recrutement
        • Chesapeake Regional Healthcare (Data Collection Only)
        • Contact:
          • Stephen Noble, MD
          • Numéro de téléphone: 757-842-4499

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 100 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

Site Eligibility

  • Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
  • Reports a clinic volume of at least 20 new lung cancer patients per month as per self report

OCP Participant Eligibility

  • OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
  • OCP conducts consultations with lung cancer patients, as per self-report;
  • OCP sees at least 1 lung cancer patient per week, as per self-report;

Patient Eligibility

  • Patient under the care of a participating OCP as per self report;

  • English and/or Spanish speaking;

    • In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
    • If English, treat as fluent in English, no additional language questions
    • If Spanish, treat as fluent in Spanish, no additional language questions
    • If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
    • How well do you speak English? Not at all/ Not well/Well/Very well
    • How well do you speak Spanish? Not at all/Not well/Well/Very well
  • Is at least 18 years of age as per self report;

  • Has a history of suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;

  • Is a former or current smoking as per self report;

  • Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report

Exclusion Criteria:

Patient Exclusion

  • Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.

Site and OCP Exclusion

  • None

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Double

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Oncology Care Providers/OCP-intervention group

Providers participate in Empathic Communication Skills (ECS) training

The overall training goal of this 2.25 hour module ECS module is to enhance OCP recognition and responsiveness to lung cancer patients' empathic opportunities by communicating understanding, alleviating stigma and distress, and providing support. The ECS training also provides tools to OCPs to buffer/inoculate patients against stigmatizing attitudes and behaviors by others such that lung cancer patients who currently or formerly smoked can be given "small doses" of an opposing viewpoint (termed as "preparing patients for recurring smoking questions") and suggestions of "counterarguments" in order to make them resistant to future stigmatizing attacks by others

Comparateur actif: Oncology Care Providers/OCP-control group

Providers complete all study measures and are offered ECS training after data collection is completed at their site.

Standard of Care participant interaction

Expérimental: Participants with Lung Cancer-intervention group

Participants will engage with oncology care providers/OCP who have undergone Empathic Communication Skills (ECS) training

The overall training goal of this 2.25 hour module ECS module is to enhance OCP recognition and responsiveness to lung cancer patients' empathic opportunities by communicating understanding, alleviating stigma and distress, and providing support. The ECS training also provides tools to OCPs to buffer/inoculate patients against stigmatizing attitudes and behaviors by others such that lung cancer patients who currently or formerly smoked can be given "small doses" of an opposing viewpoint (termed as "preparing patients for recurring smoking questions") and suggestions of "counterarguments" in order to make them resistant to future stigmatizing attacks by others

Comparateur actif: Participants with Lung Cancer-control group

Waitlist control group - WLC

Standard of Care participant interaction

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Uptake of communication skills using standardized patient assessment/SPAs
Délai: 3 months

A SPA involves a 12-minute video recorded interaction between the Oncology Care Provider/OCP and the Standardized Patient/SP on a given clinical scenario, using standardized scripts by the SP. Each OCP will participate in one SPA prior to their ECS training and one SPA following training or the timed control period. In contrast to clinical consultation recordings with varied clinical situations that do not necessitate the use of all strategies and skills, the semi-structured nature of SPAs permits appraisal of all desired elements of training.

3 months
Uptake of empathy skills using standardized patient assessment/SPAs
Délai: 3 months

A SPA involves a 12-minute video recorded interaction between the Oncology Care Provider/OCP and the Standardized Patient/SP on a given clinical scenario, using standardized scripts by the SP. Each OCP will participate in one SPA prior to their ECS training and one SPA following training or the timed control period. In contrast to clinical consultation recordings with varied clinical situations that do not necessitate the use of all strategies and skills, the semi-structured nature of SPAs permits appraisal of all desired elements of training.

3 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Smita Banerjee, PhD, Memorial Sloan Kettering Cancer Center

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

28 avril 2023

Achèvement primaire (Estimé)

31 août 2027

Achèvement de l'étude (Estimé)

31 août 2027

Dates d'inscription aux études

Première soumission

8 juillet 2022

Première soumission répondant aux critères de contrôle qualité

8 juillet 2022

Première publication (Réel)

13 juillet 2022

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

7 octobre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

6 octobre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner